Opportunity Information: Apply for RFA MH 23 115

The National Institutes of Health (NIH) funding opportunity titled "Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)" (RFA-MH-23-115) supports research aimed at clarifying how adolescent social media use and mental health influence one another over time. The central idea is not simply whether social media is "good" or "bad," but how patterns of social media engagement may shape psychiatric symptoms and overall mental health, and how an adolescent's existing symptoms, vulnerabilities, or strengths may in turn drive the way they use social media. For this announcement, social media is defined broadly as internet-based communication platforms and applications that allow users to interact by sharing or consuming information, which can include a wide range of services and features (for example, posting, commenting, direct messaging, feeds, stories, livestreams, and other interactive functions).

The FOA is focused on adolescents, defined here as ages 10 through 20, reflecting a developmental window when access to phones and online platforms expands and young people gain more independence in how, when, and why they use digital tools. Projects funded under this opportunity are expected to strengthen the evidence base around risk and resilience for psychopathology in relation to social media, including psychiatric symptoms and mental health trajectories. A key emphasis is the bidirectional nature of effects: applicants should be thinking in terms of feedback loops (for example, whether anxiety or depression predicts certain kinds of online behaviors, and whether those behaviors then worsen, maintain, or sometimes alleviate symptoms depending on context, content, and individual differences).

This is an R01 grant mechanism, meaning it is designed for substantial, hypothesis-driven research projects that can support multi-year, well-powered studies. The "Clinical Trial Optional" designation means applications may include a clinical trial if appropriate, but there is an important limitation: the announcement explicitly states that no effectiveness or efficacy trials will be accepted. In practice, this steers applicants away from testing whether an intervention works (or works better than another) and toward studies that are observational, mechanistic, developmental, or otherwise explanatory in nature, or that involve experimental approaches that do not amount to an efficacy/effectiveness evaluation. The spirit of the FOA is to understand relationships and mechanisms rather than to validate interventions as treatments or preventive programs.

Eligible applicants are broad and include many types of U.S. and non-U.S. organizations. In addition to the common categories such as state, county, city, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities; and a range of nonprofit organizations (both 501(c)(3) and non-501(c)(3)), the FOA also allows for-profit organizations (other than small businesses) and small businesses to apply. The announcement also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, non-domestic (non-U.S.) entities, and U.S. territories or possessions. This broad eligibility signals interest in diverse settings, populations, and research partnerships, including work that can better represent adolescents from different cultural, geographic, and socioeconomic contexts.

In terms of logistics, the opportunity falls under the NIH health research activity category and is associated with CFDA number 93.242. The original closing date listed for the FOA was March 24, 2023, and the record creation date is December 29, 2022. The provided source data does not specify an award ceiling or the expected number of awards, which often means applicants should consult the full FOA text and NIH budget guidance to understand typical R01 budget expectations and any institute-specific limits or recommendations.

Overall, this FOA is best understood as a call for rigorous adolescent mental health research that takes social media seriously as a dynamic, interactive environment and seeks to disentangle timing, directionality, and underlying processes. Competitive projects would be expected to move beyond simple screen-time totals and instead capture meaningful aspects of social media exposure and behavior (such as types of engagement, social context, content and interactions, and differences between passive consumption and active participation), while also using strong mental health measurement and designs capable of testing reciprocal effects across development.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2022-12-29.
  • Applicants must submit their applications by 2023-03-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA MH 23 115

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the title and identifier of this NIH funding opportunity?

The opportunity is titled "Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)" and its FOA number is RFA-MH-23-115.

What is the main goal of this FOA?

The goal is to support research that clarifies how adolescent social media use and mental health influence each other over time. The emphasis is on directionality and feedback loops (for example, how symptoms may shape online behavior, and how online behavior may then worsen, maintain, or sometimes alleviate symptoms depending on context and individual differences).

Is this FOA asking whether social media is simply "good" or "bad"?

No. The central idea is not a simplistic "good vs. bad" framing. Instead, the FOA prioritizes research on patterns of engagement, context, content, and individual differences, and how these factors relate to psychiatric symptoms and mental health trajectories over time.

How does this FOA define "social media"?

Social media is defined broadly as internet-based communication platforms and applications that allow users to interact by sharing or consuming information. Examples of features include posting, commenting, direct messaging, feeds, stories, livestreams, and other interactive functions.

Who counts as an adolescent for this funding opportunity?

For this FOA, adolescents are defined as ages 10 through 20.

Why does the FOA focus on ages 10 through 20?

This age range reflects a developmental window when access to phones and online platforms expands and young people gain more independence in how, when, and why they use digital tools.

What kinds of mental health outcomes is this FOA concerned with?

The FOA focuses on psychopathology risk and resilience in relation to social media, including psychiatric symptoms and mental health trajectories. It is oriented toward understanding how symptoms and overall mental health change over time in connection with social media engagement.

What does "bidirectional influences" mean in practical research terms?

It means studies should consider reciprocal effects over time, such as whether anxiety or depression predicts certain online behaviors, and whether those behaviors then worsen, maintain, or sometimes alleviate symptoms. The FOA encourages thinking in terms of feedback loops rather than one-way causation.

What grant mechanism is being used?

This is an NIH R01 mechanism, intended for substantial, hypothesis-driven research projects that can support multi-year, well-powered studies.

What does "Clinical Trial Optional" mean here?

It means an application may include a clinical trial if appropriate to the research question, but a clinical trial is not required.

Are clinical trials allowed under this FOA?

Clinical trials may be included, but there is an important limitation: the FOA explicitly states that no effectiveness or efficacy trials will be accepted.

What is the limitation on trials (effectiveness/efficacy) and why does it matter?

The FOA will not accept studies designed to test whether an intervention works (efficacy) or works in real-world conditions (effectiveness). This steers applications away from validating interventions as treatments or preventive programs, and toward studies that are observational, mechanistic, developmental, or otherwise explanatory in nature.

What types of study approaches are most aligned with the FOA's intent?

Based on the description provided, the FOA is aligned with research that aims to understand relationships and mechanisms, including observational, mechanistic, developmental, and explanatory approaches. It also supports designs capable of testing reciprocal effects across development rather than simple one-direction associations.

What does the FOA suggest about measuring social media use?

Competitive projects are expected to move beyond simple screen-time totals and instead capture meaningful aspects of social media exposure and behavior, such as types of engagement, social context, content and interactions, and differences between passive consumption and active participation.

What kinds of social media engagement features might be relevant to study?

The FOA mentions a wide range of interactive functions that could be relevant, including posting, commenting, direct messaging, feeds, stories, livestreams, and other interactive features. The broader implication is to measure specific behaviors and experiences, not just time spent.

What does the FOA emphasize about mental health measurement?

It emphasizes using strong mental health measurement and study designs capable of testing reciprocal effects across development, with attention to psychiatric symptoms and overall mental health trajectories over time.

Who is eligible to apply for this funding opportunity?

Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Examples include government entities (state, county, city, special district), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, tribal governments and tribal organizations (including those not federally recognized), public housing authorities, nonprofit organizations (501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), and small businesses.

Are non-U.S. (non-domestic) organizations eligible?

Yes. The FOA explicitly allows non-domestic (non-U.S.) entities to apply.

Are U.S. territories or possessions eligible to apply?

Yes. The FOA includes U.S. territories or possessions among eligible applicant types.

Are minority-serving institutions specifically mentioned as eligible?

Yes. The FOA highlights eligibility for Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).

Can faith-based or community-based organizations apply?

Yes. Faith-based and community-based organizations are listed among the eligible applicant types.

Can federal agencies apply?

Yes. The FOA includes eligible federal agencies.

What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.242.

What is the NIH activity category for this opportunity?

The opportunity falls under the NIH health research activity category.

When was the FOA record created, and what was the original closing date?

The record creation date is December 29, 2022, and the original closing date listed is March 24, 2023.

Does the provided information specify an award ceiling or expected number of awards?

No. The provided source data does not specify an award ceiling or the expected number of awards.

What does it mean that the award ceiling and number of awards are not specified in the provided data?

It generally means you may need to consult the full FOA text and NIH budget guidance to understand typical R01 budget expectations and any institute-specific limits or recommendations, since they are not included in the source details provided here.

What would a "competitive" proposal look like based on the FOA summary provided?

Based on the description, competitive proposals would likely: (1) focus on adolescents ages 10-20; (2) test bidirectional, over-time relationships between social media use and mental health; (3) incorporate designs capable of evaluating reciprocal effects and timing across development; (4) measure social media in nuanced ways (context, content, interaction types, passive vs. active use) rather than only total screen time; and (5) avoid efficacy/effectiveness trials while emphasizing explanatory mechanisms and trajectories.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Center (U24 Clinical Trial Not Allowed)

Previous opportunity: GPD Per Diem Only Grant Program (PDO)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA MH 23 115

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA MH 23 115) also looked into and applied for these:

Funding Opportunity
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) Apply for RFA MH 23 116

Funding Number: RFA MH 23 116
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed) Apply for PAR 23 069

Funding Number: PAR 23 069
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Research Centers in Minority Institutions (RCMI) (U54 Clinical Trial Optional) Apply for RFA MD 23 001

Funding Number: RFA MD 23 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,500,000
Laboratories to Optimize Digital Health (R01 Clinical Trial Required) Apply for PAR 23 096

Funding Number: PAR 23 096
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in TBI-related dementia and/or VCID (U24 - Clinical Trials Not Allowed) Apply for RFA NS 23 002

Funding Number: RFA NS 23 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional) Apply for PAR 23 092

Funding Number: PAR 23 092
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required) Apply for PAR 23 094

Funding Number: PAR 23 094
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) Apply for PAR 23 097

Funding Number: PAR 23 097
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) Apply for PAR 23 091

Funding Number: PAR 23 091
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) Apply for PAR 23 093

Funding Number: PAR 23 093
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) Apply for PAR 23 095

Funding Number: PAR 23 095
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) Apply for RFA OD 23 001

Funding Number: RFA OD 23 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) Apply for PAR 23 070

Funding Number: PAR 23 070
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) Apply for PAR 23 071

Funding Number: PAR 23 071
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) Apply for RFA NS 23 012

Funding Number: RFA NS 23 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) Apply for PAR 23 082

Funding Number: PAR 23 082
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) Apply for RFA HL 24 004

Funding Number: RFA HL 24 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $317,000
Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Center (U24 Clinical Trial Not Allowed) Apply for RFA HL 24 003

Funding Number: RFA HL 24 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed) Apply for PAR 23 073

Funding Number: PAR 23 073
Agency: National Institutes of Health
Category: Health
Funding Amount: $75,000
Pediatric Heart Network Clinical Research Centers (UM1 Clinical Trial Optional) Apply for RFA HL 24 001

Funding Number: RFA HL 24 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $281,250

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 23 115", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: